AYTU BIOPHARMA, INC Proceeds from Related Party Debt
AYTU BIOPHARMA, INC (AYTU) reported Proceeds from Related Party Debt of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2020-10-06
- AYTU BIOPHARMA, INC proceeds from related party debt for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC proceeds from related party debt for the quarter ending 2015-06-30 was $3.70M, a 67172.73% increase year-over-year.
- AYTU BIOPHARMA, INC proceeds from related party debt for the quarter ending 2015-02-28 was $4.50K, a 44.27% decline year-over-year.
- AYTU BIOPHARMA, INC proceeds from related party debt for the quarter ending 2014-11-30 was $1.01K, a 81.47% decline year-over-year.
- AYTU BIOPHARMA, INC proceeds from related party debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AYTU BIOPHARMA, INC proceeds from related party debt for fiscal 2019 was $5.00M.
- AYTU BIOPHARMA, INC proceeds from related party debt for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- AYTU BIOPHARMA, INC proceeds from related party debt for fiscal 2015 was $7.40M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month | Proceeds from Related Party Debt 81 month | Proceeds from Related Party Debt 84 month | Proceeds from Related Party Debt 87 month | Proceeds from Related Party Debt 90 month | Proceeds from Related Party Debt 93 month | Proceeds from Related Party Debt 96 month | Proceeds from Related Party Debt 99 month | Proceeds from Related Party Debt 102 month | Proceeds from Related Party Debt 105 month | Proceeds from Related Party Debt 108 month | Proceeds from Related Party Debt 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $0.00 10-K · filed 2020-10-06 | ||||||||||||||
| 2019-06-30 | $5.00M 10-K · filed 2020-10-06 | ||||||||||||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 10-K · filed 2016-09-01 | |||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-11 | ||||||||||||||
| 2015-06-30 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $7.40M 10-K · filed 2016-09-01 | |||||||||||||
| 2015-03-31 | $3.70M 10-Q · filed 2016-05-11 | ||||||||||||||
| 2015-02-28 | $4.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $5.51K 10-Q · filed 2015-04-15 | |||||||||||||
| 2014-11-30 | $1.01K 10-Q · filed 2015-01-12 | ||||||||||||||
| 2014-05-31 | $5.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $13.57K derived: sum of 2 quarters · filed 2015-04-15 | $19.02K 10-Q · filed 2014-07-10 | $22.38K derived: sum of 4 quarters · filed 2015-04-15 | $173.68K 10-Q · filed 2014-07-10 | ||||||||||
| 2014-02-28 | $8.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $13.52K 10-Q · filed 2015-04-15 | $16.88K derived: sum of 3 quarters · filed 2015-04-15 | $29.70K derived: sum of 4 quarters · filed 2015-04-15 | $168.18K 10-Q · filed 2014-04-11 | ||||||||||
| 2013-11-30 | $5.44K 10-Q · filed 2015-01-12 | $8.81K derived: sum of 2 quarters · filed 2015-01-12 | $21.62K derived: sum of 3 quarters · filed 2015-01-12 | $32.39K derived: sum of 4 quarters · filed 2015-01-12 | $160.10K 10-Q · filed 2014-01-10 | ||||||||||
| 2013-08-31 | $3.37K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $16.18K derived: sum of 2 quarters · filed 2014-11-26 | $26.95K derived: sum of 3 quarters · filed 2014-11-26 | $31.46K 10-K · filed 2014-11-26 | $154.66K 10-K · filed 2014-11-26 | ||||||||||
| 2013-05-31 | $12.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $23.58K derived: sum of 2 quarters · filed 2014-07-10 | $28.09K 10-Q · filed 2014-07-10 | $40.71K derived: sum of 4 quarters · filed 2014-11-26 | $151.29K 10-Q · filed 2013-06-28 | ||||||||||
| 2013-02-28 | $10.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | $15.27K 10-Q · filed 2014-04-11 | $27.90K derived: sum of 3 quarters · filed 2014-11-26 | $28.28K derived: sum of 4 quarters · filed 2014-11-26 | $138.48K 10-Q · filed 2013-04-15 | ||||||||||
| 2012-11-30 | $4.51K 10-Q · filed 2014-01-10 | $17.13K derived: sum of 2 quarters · filed 2014-11-26 | $17.51K derived: sum of 3 quarters · filed 2014-11-26 | $17.51K derived: sum of 4 quarters · filed 2014-11-26 | $127.71K 10-Q · filed 2013-01-14 | ||||||||||
| 2012-08-31 | $12.63K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $13.01K derived: sum of 2 quarters · filed 2014-11-26 | $13.01K derived: sum of 3 quarters · filed 2014-11-26 | $16.75K 10-K · filed 2014-11-26 | $123.20K 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | $380.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $380.00 derived: sum of 2 quarters · filed 2013-06-28 | $4.13K 10-Q · filed 2013-06-28 | $7.91K derived: sum of 4 quarters · filed 2013-06-28 | $110.58K 10-Q · filed 2012-06-26 | ||||||||||
| 2012-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $3.75K 10-Q · filed 2013-04-15 | $7.53K derived: sum of 3 quarters · filed 2013-04-15 | $21.77K derived: sum of 4 quarters · filed 2013-04-15 | $110.20K 10-Q · filed 2012-04-12 | ||||||||||
| 2011-11-30 | $3.75K 10-Q · filed 2013-01-14 | $7.53K derived: sum of 2 quarters · filed 2013-01-14 | $21.77K derived: sum of 3 quarters · filed 2013-01-14 | $33.27K derived: sum of 4 quarters · filed 2013-01-14 | $110.20K 10-Q · filed 2011-12-23 | ||||||||||
| 2011-08-31 | $3.78K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $18.02K derived: sum of 2 quarters · filed 2012-11-29 | $29.52K derived: sum of 3 quarters · filed 2012-11-29 | $35.77K 10-K · filed 2012-11-29 | |||||||||||
| 2011-05-31 | $14.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | $25.74K derived: sum of 2 quarters · filed 2012-06-26 | $31.99K 10-Q · filed 2012-06-26 | ||||||||||||
| 2011-02-28 | $11.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | $17.74K 10-Q · filed 2012-04-12 | |||||||||||||
| 2010-11-30 | $6.25K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |